Arch Invest Med (Mex). 1991 Jan-Mar;22(1):45-50.

Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.

Avilés A, Díaz-Maqueo JC, García EL, Torras V, López-Vancell D.

Source

Department of Hematology, Oncology Hospital, National Medical Center, I.M.S.S., México City, D.F.

Abstract

Between January 1983 and December 1984, 83 patients with advanced Hodgkin's disease were entered in a prospective randomized trial comparing MOPP (mechlorethamine, vincristine, procarbazine and prednisone) with a regimen containing chlorambucil (Leukeran), vincristine, prednisone and procarbazine (LOPP). Both groups were comparable for the variables of age, stage, symptoms, histology and sites of involvement. Seventy percent of LOPP-treated patients achieved a complete remission compared to 65% of the MOPP-treated group. After a median follow-up of greater than 48 months, there is no statistical difference between the two treatment groups in survival or relapse free-survival. The LOPP combination was better tolerated with significantly less side effects. The drug regimen LOPP appears to be as effective as MOPP in producing complete remission and long term survival in patients with advanced Hodgkin's disease.

PMID:: 1819976; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Supplementary Concepts

Publication Types

MeSH Terms

Substances

Supplementary Concepts

LinkOut - more resources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. [Cancer Treat Rep. 1983]
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR. Cancer Treat Rep. 1983 May; 67(5):413-9.
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results. [Br J Cancer. 1991]
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
Hancock BW, Vaughan Hudson G, Vaughan Hudson B, Haybittle JL, Bennett MH, MacLennan KA, Jelliffe AM. Br J Cancer. 1991 Apr; 63(4):579-82.
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. [Radiother Oncol. 1986]
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
Hancock BW. Radiother Oncol. 1986 Nov; 7(3):215-21.
Review [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. [Sangre (Barc). 1998]
Review [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM. Sangre (Barc). 1998 Jun; 43(3):179-84.
Review Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease? [Hematol J. 2000]
Review Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Carde P, Cavalli F, Diehl V, Franklin J. Hematol J. 2000; 1(4):282-90.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Arch Invest Med (Mex). 1991 Jan-Mar ;22(1):45-50.

PubMed
Visualizing cold spots: TRPM8-expressing sensory neurons and their projections.
Visualizing cold spots: TRPM8-expressing sensory neurons and their projections.
J Neurosci. 2008 Jan 16 ;28(3):566-75.

PubMed
Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-b...
Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study.
Cancer Epidemiol Biomarkers Prev. 2008 Jan ;17(1):252-4.

PubMed
Dietary vitamin B6 intake and the risk of colorectal cancer.
Dietary vitamin B6 intake and the risk of colorectal cancer.
Cancer Epidemiol Biomarkers Prev. 2008 Jan ;17(1):171-82.

PubMed
A prospective study of trans-fatty acid levels in blood and risk of prostate can...
A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
Cancer Epidemiol Biomarkers Prev. 2008 Jan ;17(1):95-101.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: